Industry News

Novartis to Invest $250 Million for R&D of Neglected Tropical Diseases

June 24, 2022

Novartis will endorse the Kigali Declaration on neglected tropical diseases and invest $250 million for R&D.

GSK Announces £1 Billion R&D Investment in Fighting Infectious Diseases in Lower-Income Countries

June 24, 2022

GSK will invest £1 billion in furthering R&D in malaria, tuberculosis, and HIV, as well as neglected tropical diseases.

FDA Leaders Seek to Build Public Trust in Science and Gain Support for Regulation

June 22, 2022

FDA is at a pivotal moment because of important gains in medical treatment based on science.

Sustainable Medicines Packaging Award Winners to be Announced at Connect in Pharma

June 21, 2022

Connect in Pharma will host an awards ceremony to showcase innovations in sustainable pharmaceutical packaging.

EMA Starts Rolling Review of Adapted COVID-19 Vaccines

June 21, 2022

The agency will review laboratory study and CMC data on the bivalent vaccine that targets two strains of the SARS-CoV-2 virus.

International Collaboration on Pharmaceutical Regulations

June 21, 2022

Lessons learned from the COVID-19 pandemic about the benefits of international collaboration were discussed in a May 2022 workshop.

Orbit Discovery Awarded Innovate UK Grant

June 21, 2022

Orbit Discovery has been awarded the Innovate UK Grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery.

FDA Authorizes COVID-19 Vaccines for Individuals Six Months and Older

June 17, 2022

FDA has issued an Emergency Use Authorization for the Moderna and Pfizer-BioNTech COVID-19 vaccines in children as young as six months old.

Aptamer Group Signs Deal with Flip Gene Therapeutics

June 17, 2022

Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.

Boehringer Ingelheim to Acquire Trutino Biosciences

June 17, 2022

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.